Page 10 - MemoriaSAM-Eng
P. 10




ORGANIZATION



The Permanent Commission consists of the Vice-president of the Board of Trustees, 
Permanent 
the Scientific Director of the Consortium, the General Manager of the Consortium, who 
Commission
will act as the Secretary, and four members representing the Consortium Institutions. 

The Permanent Commission evaluates the Consortium’s activities, and reviews and 

prepares budgets, accounts and other reports to be approved by the Board of Trustees.



Members of the Permanent Commission

Instituto de Salud Carlos III (ISCIII)
Margarita Blázquez Herranz (President of the Board) 
CIBERSAM. General Manager
Manuel Sánchez Delgado (Secretary of the Board) 

CIBERSAM. Scientific Director
Celso Arango López

Fundación para la Investigación y 
Docencia Sant Joan de Deu
Emilli Bargalló Angerri 

Universidad de Granada
María Dolores Suárez Ortega Á
í
Fundación Vasca de Innovación e 
Investigación Sanitarias
Carmen Garaizar Axpe 

Universidad de Oviedo
Ma Paz Suárez Rendueles
íé
á
í
á
External Scientific The External Scientific Advisory Committee provides general scientific support and á
advice to the Board of Trustees. It consists of internationally renowned scientists in 
Advisory 
the health sciences field whose professional and scientific careers align with CIBERSAM 
Committee
é
objectives. The members of this committee include:


Mr. Jim Van Os.
Ms. Maria Ron.
é
Maastricht University. Holland
Institute of Neurology, University 
College London, Queen Square, 
Mr. Guy Goodwin.
Londres. Reino Unido
Department of Psychiatry, University Of 
Oxford, Warnerford Hospital. Reino Unido
Ms. Marion Leboyer.

Mr. Michael Hamon
Groupe Henri Mondor- Albert 
Chenevier, Pôle de Psychiatrie, Créteil, 
Institut National de la Sant et de la 
Paris. Francia
Recherche, Universit Pierre et Marie 
Curie, Pars. Francia



Steering The Steering Committee consists of a collegial body which assures the development of the 
Consortium by looking into the needs of the groups and their strategic objectives. This 
Committee
committee includes:



Dr. Celso Arango
Scientific Director

Dr. Francesc Artigas
Therapeutic Innovation Programme Manager
13
0
Dr. Vctor Prez
Depression Programme Manager
 2
RT
Dr. Eduard Vieta
Bipolar Disorder Programme Manager
O
EP
Dr. Julio Sanjun
Schizophrenia Programme and Common Databases Manager
 R
AL
Dr. Antonio Lobo
Psychotic, Anxiety, and Impulse Control Disorders Programme U
Manager
NN
A
Dr. ngel Pazos
Training and Mobility Manager
 / 
M
Dr. Josep Mara Haro
Platforms Manager
SA
R
Dr. Josefina Castro
Child and Adolescent Psychiatry Prog. Manager
BE
CI
Dr. Ana Ma Gonzlez-Pinto
Quality Manager
10
D. Manuel Snchez
General Manager






   8   9   10   11   12